"Nirmal hospital is a multispecialty hospital in Surat comprising of 12 health departments. With our team of experienced doctors in various fields and our use of the latest technology, we are the best super specialty hospital in Surat. We have the best pediatricians in Surat with the latest technology having an 87.3% Survival rate in PICU. Having solved complex neonatal cases we are the best neonatologist in Surat. We provide various surgeries related to bones and joints. We are the best orthopedic hospital in Surat. We are 24-hour stroke ready to provide 24-hour stroke treatment, this makes us the best neurologist in Surat. We have a dialysis unit and our doctors are experts in treating ailments related to nephrology and urology."

During the past decade, Nirmal Hospital Pvt Ltd conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 15 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 13 clinical trials were completed. i.e. 68.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nirmal Hospital Pvt Ltd" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Pfizer" with 8 trials sponsored, "Gilead Sciences" with 4 trials sponsored, "Daiichi Sankyo, Inc." with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nirmal Hospital Pvt Ltd" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Lambda Therapeutic Research Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nirmal Hospital Pvt Ltd" are "Ulcerative Colitis" (7 trials), "Atopic Dermatitis" (2 trials), "HBV" (2 trials), "Hemophilia A" (2 trials) and "Hemophilia B" (2 trials). Many other conditions were trialed in "Nirmal Hospital Pvt Ltd" in a lesser frequency.

Most popular intervention types in "Nirmal Hospital Pvt Ltd" are "Drug" (35 trials), "Biological" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Etrasimod" (3 trials), "Baricitinib" (2 trials), "Doxorubicin Hydrochloride Liposome Injection" (2 trials) and "Edoxaban" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nirmal Hospital Pvt Ltd" are 32 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Nirmal Hospital Pvt Ltd". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Nirmal Hospital Pvt Ltd, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nirmal Hospital Pvt Ltd, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 0 trials that are defined as “Not Applicable".